BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

DNA Genotek Submits Filing for 510(k) Clearance


3/15/2011 9:42:13 AM

OTTAWA, ON, March 15, 2011. DNA Genotek Inc. a leading provider of products for biological sample collection, stabilization and preparation, announced today that it has completed filing a 510(k) pre market submission to the U.S. Food and Drug Administration for its Oragene®•Dx family of products.

Oragene products are recognized for enabling non-invasive and reliable collection of DNA from saliva samples and for isolating and stabilizing DNA for transport and storage. Oragene•Dx is the newest addition to the family of products and will be commercially available upon clearance by the FDA.

Ian Curry, president and CEO of DNA Genotek Inc. said “We have filed for 510(k) clearance status on our Oragene•Dx products to reinforce the proven performance, safety and efficacy we have already demonstrated with thousands of customers in more than 100 countries around the world. We feel it is imperative for labs and molecular test manufacturers worldwide to have access to the highest quality, proven, non-invasive collection methods to enable genetic testing.” Added Curry, “We believe that the successful completion of this 510(k) clearance will facilitate broad use of Oragene•Dx in molecular diagnostics. We continue to see an expanding set of important, valuable applications for clinical diagnostics and personalized medicine. We have filed our submission and now the final decision is with the U.S. Food and Drug Administration.”

About DNA Genotek:

DNA Genotek focuses on providing high-quality biological sample collection products. The company’s Oragene family of products provides the best way to collect and preserve large amounts of DNA or RNA from saliva. The company also offers a family of products for collecting DNA from animals and livestock. The reliability and ease-of-use of the company’s products have resulted in rapid adoption at top-tier health research institutions globally, including Harvard, Stanford, Cambridge, and Johns Hopkins. DNA Genotek markets its products worldwide and has established a global customer base in over 100 countries. For more information about DNA Genotek, visit www.dnagenotek.com

For information about this press release contact:

Shauna White DNA Genotek Inc. 613-723-5757 ext. 307 shauna.white@dnagenotek.com

® Oragene is a registered trademark of DNA Genotek Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES